CCChao Chen

Chao Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chao Chen has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Weidong Pan

    State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang, 561113, China

    6 shared publications
  • Xiuhai Gan

    Center for R&D of Fine Chemicals of Guizhou University

    4 shared publications
  • Xue-Yi Zeng

    State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China

    4 shared publications
  • Heng Luo

    State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China

    3 shared publications
  • Jun-Rong Song

    State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China

    3 shared publications
  • Jun Luo

    The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang 550014, China

    2 shared publications

Latest Publications

  • Structure-Based Rational Design and Synthesis of Pyridazinone Herbicides Targeting Phytoene Desaturase

    by Chao Chen, Yan Li, Wei Zhang, Xiuhai Gan

    The application of herbicides plays a critical role in ensuring food security. However, the long-term overuse of herbicides can lead to a range of adverse effects. Therefore, it is essential to develop innovative and sustainable herbicides. A series of pyridazinone derivatives targeting phytoene desaturase (PDS) were designed and synthesized by using a structure-based drug design strategy. A bioassay showed that 16c (100%, 85%) exhibited stronger herbicidal activity against portulaca oleracea (P.o.) than that of norflurazon (NRF, 60%, 45%) in both post- and pre-emergence applications at a dosage of 150 g a.i./ha, while also showing greater safety to nontarget organisms. Meanwhile, levels of 15-cis-phytoene, carotenoids, and chlorophyll revealed that 16c effectively inhibited PDS activity. Molecular dynamics simulations and binding action assays confirmed that Arg195 is a key residue for the interaction between 16c and Synechococcus PDS (SynPDS). Therefore, 16c could be developed as a potent PDS inhibitor for herbicides.

  • Discovery of Potential Acetohydroxyacid Synthase Covalent Inhibitors with Integrated Virtual Screening Approach

    by Fangping Zhong, Wei Zhang, Yan Li, Chao Chen, Xiuhai Gan

    Acetohydroxyacid synthase (AHAS) is an important target for over 50 commercial herbicides. However, increasing herbicide resistance in weeds has made control difficult, and developing covalent inhibitors may be an effective strategy. Here, a hybrid virtual screening strategy combining structure-based, ligand-based, and molecular simulation calculations was developed based on covalent binding effects and first employed to discover potential AHAS covalent inhibitors. A refined database of 5178 sulfonyl fluoride-containing small molecules was obtained via pesticide similarity screening. The database was initially screened by noncovalent docking, and higher-scoring compounds were reranked using integrated 2D and 3D similarity search tools to obtain 723 molecules. Two potential covalent inhibitors, Z2768276635 and Z2901771932, were successfully screened by covalent docking and DFT calculations. Notably, Z2768276635 showed excellent inhibitory activity against AtAHAS with a Ki value of 0.12 μM, superior to bispyribac (0.44 μM). This work offers a meaningful starting point for developing covalent inhibitor pesticides.

  • Investigating the Impact of C3-Methyl of Naphtho[1,2-b]Furan-4,5-Dione Analogs for Anticancer Activity

    by Yue Zhu, Jia Yu, Xin Tan, Ni Zhang, Jin-Yu Li, Hua-Yong Lou, Heng Luo, Chao Chen, Wei-Dong Pan

  • Novel Phenylpyrazole Derivatives Containing Carbonic Ester Moieties as Protoporphyrinogen IX Oxidase Inhibitors

    by Yangwen Yan, Wang Geng, Chao Chen, Kai Yan, Xiuhai Gan

    Protoporphyrinogen IX oxidase (PPO) is an essential enzyme in the chlorophyll synthesis process in plants, making it a major target for the advancement of environmentally safe herbicides. In order to develop new PPO inhibition herbicides, a series of novel pyrazole derivatives containing carbonic ester moieties were synthesized based on the active splicing principle and structural simplification strategy. In bioassays, it was found that the majority of the target compounds had a good inhibitory effect on Nicotiana tabacum PPO (NtPPO) and displayed herbicidal activity against the tested weeds. Among them, compound A20 (Ki = 15.2 nM) not only exhibited an inhibitory effect on NtPPO superior to that of pyraflufen-ethyl (Ki = 31.1 nM) and fluazolate (Ki = 18.3 nM) but also showed more than 90% herbicidal activity against dicotyledonous weeds at 9.375 g of a.i./ha, and its herbicidal activity was better than that of pyraflufen-ethyl and fluazolate. Additionally, compound A20 caused lower damage to wheat, rice, corn, soybeans, peanuts, and cotton compared to pyraflufen-ethyl and fluazolate. Molecular docking revealed that there are two hydrogen bonds between compound A20 and the Arg98 (2.8 and 3.0 Å) residue of NtPPO, which were stronger than those of pyraflufen-ethyl (2.9 Å) and fluazolate (2.9 and 3.6 Å). Density functional theory calculations clarified the differences of the target compounds in herbicidal activity. The current study suggests that compound A20 shows potential as a PPO inhibitor for creating an ecofriendly herbicide to manage weeds in agricultural fields.


  • Pyridazine: A privileged scaffold in the development of 21st-century pesticides

    by Chao Chen, Wang Geng, Ke Li, Qiong Lei, Zhichao Jin, Xiuhai Gan


  • Open Access

    Design, Synthesis of Novel Tetrandrine-14-l-Amino Acid and Tetrandrine-14-l-Amino Acid-Urea Derivatives as Potential Anti-Cancer Agents

    by Sheng-Cao Hu, Jin Yang, Chao Chen, Jun-Rong Song, Wei-Dong Pan

    Tetrandrine, a dibenzyltetrahydroisoquinoline alkaloid isolated from the root of the traditional Chinese medicinal plant Stephania tetrandra S. Moore, a member of the Menispermaceae, showed anti-cancer activity by inhibiting cell proliferation, preventing cell cycle progress and induction of cell death and autophagy. In this study, twelve tetrandrine-l-amino acid derivatives and twelve tetrandrine-14-l-amino acid-urea derivatives were designed and synthesized, using C14-aminotetrandrine as raw material. Then the preliminary in vitro anti-cancer activities of these derivatives against human breast cancer cell line MDA-MB-231, human leukemia cell lines HEL and K562 were evaluated. The in vitro cytotoxicity results showed that these derivatives exhibited potent inhibitory effects on cancer cell growth, and the primary structure-activity relationships were evaluated. Notably, compound 3f exhibited satisfactory anticancer activity against all three cancer cell lines, especially the HEL cell line, with the IC50 value of 0.23 µM. Further research showed that 3f could induce G1/S cycle arrest and apoptosis in a dose- and time- dependent manner on the leukemia cell line HEL. The results suggested that 3f may be used as a potential anti-cancer agent for human leukemia.


  • Open Access

    Potent Cytotoxicity of Novel L-Shaped Ortho-Quinone Analogs through Inducing Apoptosis

    by Sheng-You Li, Ze-Kun Sun, Xue-Yi Zeng, Yue Zhang, Meng-Ling Wang, Sheng-Cao Hu, Jun-Rong Song, Jun Luo, Chao Chen, Heng Luo, et al.

    Twenty-seven L-shaped ortho-quinone analogs were designed and synthesized using a one pot double-radical synthetic strategy followed by removing methyl at C-3 of the furan ring and introducing a diverse side chain at C-2 of the furan ring. The synthetic derivatives were investigated for their cytotoxicity activities against human leukemia cells K562, prostate cancer cells PC3, and melanoma cells WM9. Compounds TB1, TB3, TB4, TB6, TC1, TC3, TC5, TC9, TC11, TC12, TC14, TC15, TC16, and TC17 exhibited a better broad-spectrum cytotoxicity on three cancer cells. TB7 and TC7 selectively displayed potent inhibitory activities on leukemia cells K562 and prostate cancer cells PC3, respectively. Further studies indicated that TB3, TC1, TC3, TC7, and TC17 could significantly induce the apoptosis of PC3 cells. TC1 and TC17 significantly induced apoptosis of K562 cells. TC1, TC11, and TC14 induced significant apoptosis of WM9 cells. The structure-activity relationships evaluation showed that removing methyl at C-3 of the furan ring and introducing diverse side chains at C-2 of the furan ring is an effective strategy for improving the anticancer activity of L-shaped ortho-quinone analogs.


  • Open Access

    A Novel Tanshinone Analog Exerts Anti-Cancer Effects in Prostate Cancer by Inducing Cell Apoptosis, Arresting Cell Cycle at G2 Phase and Blocking Metastatic Ability

    by Mengling Wang, Xueyi Zeng, Shengyou Li, Zekun Sun, Jia Yu, Chao Chen, Xiangchun Shen, Weidong Pan, Heng Luo

    Prostate cancer (PCa), an epithelial malignant tumor, is the second common cause of cancer death among males in western countries. Thus, the development of new strategies is urgently needed. Tanshinones isolated from Salvia miltiorrhiza and its synthetic analogs show various biological activities including anticancer effects. Among them, the tanshinone analog 2-((Glycine methyl ester)methyl)-naphtho (TC7) is the most effective, with better selectivity and lower toxicity. Therefore, in this work, the effect of TC7 against PCa was investigated through assessing the molecular mechanisms regulating the growth, metastasis, and invasion of PCa cells. Human PCa cells, PC3 and LNCAP, were used to evaluate TC7 mechanisms of action in vitro, while male BALB/c nude mice were used for in vivo experiments by subjecting each mouse to a subcutaneous injection of PC3 cells into the right flank to evaluate TC7 effects on tumor volume. Our in vitro results showed that TC7 inhibited cell proliferation by arresting the cell cycle at G2/M through the regulation of cyclin b1, p53, GADD45A, PLK1, and CDC2/cyclin b1. In addition, TC7 induced cell apoptosis by regulating apoptosis-associated genes such as p53, ERK1, BAX, p38, BCL-2, caspase-8, cleaved-caspase-8, PARP1, and the phosphorylation level of ERK1 and p38. Furthermore, it decreased DNA synthesis and inhibited the migration and invasion ability by regulating VEGF-1 and MMP-9 protein expression. Our in vivo evidence supports the conclusion that TC7 could be considered as a potential promising chemotherapeutic candidate in the treatment of PCa.


  • Open Access

    Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

    by Ni Zhang, Jin Yang, Ke Li, Jun Luo, Su Yang, Jun-Rong Song, Chao Chen, Wei-Dong Pan

    Seventeen new flavone derivatives substituted at the 4′-OH position were designed, synthesized and evaluated for their anticancer and antibacterial activities. Among them, compounds 3, 4, 6f, 6e, 6b, 6c and 6k demonstrated the most potent antiproliferative activities against a human erythroleukemia cell line (HEL) and a prostate cancer cell line (PC3). The results also showed that the IC50 value of compounds 3, 4, 6f, 6e, 6b, 6c and 6k were close to that of the anticancer drug cisplatin (DDP) and lower than that of apigenin. All of the derivatives did not present antibacterial activities. The structure–activity relationships evaluation showed that the configuration of methyl amino acid might affect their biological activities.


  • Open Access

    Design and Synthesis of Flavonoidal Ethers and Their Anti-Cancer Activity In Vitro

    by Lu Jin, Meng-Ling Wang, Yao Lv, Xue-Yi Zeng, Chao Chen, Hai Ren, Heng Luo, Wei-Dong Pan

    Flavonoids are well-characterized polyphenolic compounds with pharmacological and therapeutic activities. However, most flavonoids have not been developed into clinical drugs, due to poor bioavailability. Herein, we report a strategy to increase the drugability of flavonoids by constructing C(sp2)-O bonds and stereo- as well as regioselective alkenylation of hydroxyl groups of flavonoids with ethyl-2,3-butadienoate allenes. Twenty-three modified flavonoid derivatives were designed, synthesized, and evaluated for their anti-cancer activities. The results showed that compounds 4b, 4c, 4e, 5e, and 6b exhibited better in vitro inhibitory activity against several cancer cell lines than their precursors. Preliminary structure–activity relationship studies indicated that, in most of the cancer cell lines evaluated, the substitution on position 7 was essential for increasing cytotoxicity. The results of this study might facilitate the preparation or late-stage modification of complex flavonoids as anti-cancer drug candidates.